Influence of Comorbidity in Cognitive-Behavioral Treatment of Anxiety and Mood Disorders

被引:0
作者
Philippe, Jessica [1 ]
Provencher, Martin D. [1 ,2 ]
Belleville, Genevieve [1 ,2 ]
Busque, Guillaume Foldes [1 ,2 ]
机构
[1] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada
[2] Univ Laval, Ctr Evaluat & Intervent Sante Mentale CEISM, Quebec City, PQ, Canada
来源
SANTE MENTALE AU QUEBEC | 2022年 / 47卷 / 01期
关键词
comorbidity; cognitive-behavioral therapy; anxiety disorders; mood disorders; effectiveness study; MAJOR DEPRESSIVE DISORDER; PANIC DISORDER; DSM-IV; DIAGNOSTIC COMORBIDITY; EMOTIONAL DISORDERS; RESIDUAL SYMPTOMS; PREVALENCE; PSYCHOTHERAPY; THERAPY; IMPACT;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives Anxiety and depression are the most prevalent disorders observed in health care services and are frequently comorbid with other disorders. Although Cognitive-Behavioral Therapy (CBT) has widely been shown efficacious to treat anxiety and mood disorders, studies that have focused on its effectiveness in the presence of comorbidity have been few and show conflicting results. Thus, the implications of the presence of comorbid disorders for treatment are still unknown. In an attempt to answer these questions, this study explores the impact of comorbidity on CBT for anxiety and mood disorders in a university-based clinic. Methods A total of 293 clients consulting for anxiety and/or mood disorders at the Service de Consultation de l'Ecole de Psychologie de l'Universite Laval (SCEP) between 2007 and 2018 took part in the study. Clients were excluded if they presented uncontrolled psychotic, manic or substance abuse symptoms as their principal complaint. Clients without comorbid disorders where compared to clients who had comorbid disorders on different measures before and after receiving therapy to examine if comorbidity had an impact on CBT effectiveness to treat the principal disorder. The impact of treatment on comorbid disorders was also investigated. Effectiveness was assessed on several measures before and after treatment including the severity of diagnoses (measured with a structured interview), anxiety and mood symptoms as well as quality of life. Repeated measures ANOVAs and t-tests were used. Results Before initiating therapy, clients with comorbid disorders had significantly more severe symptoms than clients without comorbid disorders. However, following therapy, both groups had significantly less severe principal disorders and reached a clinically significant change in equivalent proportions. Furthermore, the number and severity of comorbid disorders significantly decreased following therapy. Conclusion These findings suggest that although the presence of comorbid disorders leads to more severe symptoms, it does not affect the effectiveness of CBT for the principal disorder. Furthermore, comorbid disorders improved even though they were not specifically targeted by treatment. In concordance with the literature, it is thus suggested to keep focusing treatment on the principal disorder, whether comorbid disorders are present or not.
引用
收藏
页码:309 / 331
页数:23
相关论文
共 53 条
[1]   Effects of comorbid depression on response to treatment for obsessive-compulsive disorder [J].
Abramowitz, JS ;
Franklin, ME ;
Street, GP ;
Kozak, MJ ;
Foa, EB .
BEHAVIOR THERAPY, 2000, 31 (03) :517-528
[2]  
Abramowitz JS., 2013, Handbook of Treating Variants and Complications in Anxiety Disorders, P243
[3]  
ANGST J, 1990, COMORBIDITY OF MOOD AND ANXIETY DISORDERS, P123
[4]   High prevalence of mental disorders in primary care [J].
Ansseau, M ;
Dierick, M ;
Buntinkx, F ;
Cnockaert, P ;
De Smedt, J ;
Van Den Haute, M ;
Vander Mijnsbrugge, D .
JOURNAL OF AFFECTIVE DISORDERS, 2004, 78 (01) :49-55
[5]   The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions [J].
Baumann, C. ;
Erpelding, M. -L. ;
Regat, S. ;
Collin, J. -F. ;
Briancon, S. .
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2010, 58 (01) :33-39
[6]   Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder [J].
Bech, Per ;
Lonn, Sara L. ;
Overo, Kerstin F. .
JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (02) :121-129
[7]  
Beck A.T., 1998, Beck Depression Inventory II manual
[8]   AN INVENTORY FOR MEASURING CLINICAL ANXIETY - PSYCHOMETRIC PROPERTIES [J].
BECK, AT ;
BROWN, G ;
EPSTEIN, N ;
STEER, RA .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1988, 56 (06) :893-897
[9]  
Beck AT., 1996, MANUAL BECK DEPRESSI
[10]  
Belzer Kenneth, 2004, J Psychiatr Pract, V10, P296, DOI 10.1097/00131746-200409000-00003